Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders
Condition(s):Lymphoproliferative Disorders; Lymphoproliferative Disorder Following TransplantationLast Updated:April 25, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Lymphoproliferative Disorders; Lymphoproliferative Disorder Following TransplantationLast Updated:April 25, 2023Recruiting
Condition(s):Pre-cancerous Lymphoproliferative DisordersLast Updated:November 2, 2023Recruiting
Condition(s):Post-transplant Lymphoproliferative DisorderLast Updated:January 16, 2024Recruiting
Condition(s):Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder; Polymorphic Post-Transplant Lymphoproliferative DisorderLast Updated:March 22, 2024Recruiting
Condition(s):Lymphoproliferative Disorders; Premalignant; Monoclonal B-Cell Lymphocytosis; Chronic Lymphocytic LeukemiaLast Updated:February 8, 2023Not yet recruiting
Condition(s):Epstein-Barr Virus Infections; Lymphoma; Lymphoproliferative Disorder; Disorders, LymphoproliferativeLast Updated:January 9, 2024Recruiting
Condition(s):B-Cell Lymphoproliferative DisorderLast Updated:February 29, 2024Recruiting
Condition(s):Myeloproliferative Disorders; Lymphoproliferative DisordersLast Updated:March 17, 2022Not yet recruiting
Condition(s):Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD); Solid Organ Transplant Complications; Lymphoproliferative Disorders; Allogeneic Hematopoietic Cell Transplant; Stem Cell Transplant ComplicationsLast Updated:June 24, 2022Recruiting
Condition(s):Benign Lymphoproliferative DisorderLast Updated:March 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.